General Information of Drug (ID: DMRBFUA)

Drug Name
Z90308237
Synonyms
SCHEMBL18352966; BDBM113300; ZINC12619607; AKOS034677493; MCULE-1271453362; US9695194, 16; Z90308237; 1000928-01-7; 5-(2-chlorophenyl)-6,11,14-trioxa-4-azatricyclo[8.4.0.0^{3,8}]tetradeca-1,3(8),4,9-tetraen-7-one
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 315.71
Logarithm of the Partition Coefficient (xlogp) 3.3
Rotatable Bond Count (rotbonds) 1
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 5
Chemical Identifiers
Formula
C16H10ClNO4
IUPAC Name
2-(2-chlorophenyl)-7,8-dihydro-[1,4]dioxino[2,3-g][3,1]benzoxazin-4-one
Canonical SMILES
C1COC2=C(O1)C=C3C(=C2)N=C(OC3=O)C4=CC=CC=C4Cl
InChI
InChI=1S/C16H10ClNO4/c17-11-4-2-1-3-9(11)15-18-12-8-14-13(20-5-6-21-14)7-10(12)16(19)22-15/h1-4,7-8H,5-6H2
InChIKey
RMEUFAVEIHZTRM-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
25400532
TTD ID
D05CJM

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Chymotrypsin-C (CLCR) TT3RMNA CTRC_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Benzoxazinone derivatives for treatment of skin diseases. US9695194.